nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefoxitin—Azotaemia—Mechlorethamine—lymphatic system cancer	0.0353	0.0353	CcSEcCtD
Cefoxitin—Nephropathy toxic—Teniposide—lymphatic system cancer	0.0241	0.0241	CcSEcCtD
Cefoxitin—Bone marrow depression—Teniposide—lymphatic system cancer	0.0205	0.0205	CcSEcCtD
Cefoxitin—Induration—Bleomycin—lymphatic system cancer	0.02	0.02	CcSEcCtD
Cefoxitin—Bone marrow depression—Fludarabine—lymphatic system cancer	0.0181	0.0181	CcSEcCtD
Cefoxitin—Local reaction—Bleomycin—lymphatic system cancer	0.0161	0.0161	CcSEcCtD
Cefoxitin—Thrombophlebitis—Mechlorethamine—lymphatic system cancer	0.0158	0.0158	CcSEcCtD
Cefoxitin—Nephropathy toxic—Bleomycin—lymphatic system cancer	0.0156	0.0156	CcSEcCtD
Cefoxitin—Haemolytic anaemia—Mechlorethamine—lymphatic system cancer	0.0151	0.0151	CcSEcCtD
Cefoxitin—Azotaemia—Carmustine—lymphatic system cancer	0.0146	0.0146	CcSEcCtD
Cefoxitin—Azotaemia—Vincristine—lymphatic system cancer	0.014	0.014	CcSEcCtD
Cefoxitin—Nephropathy toxic—Carmustine—lymphatic system cancer	0.0136	0.0136	CcSEcCtD
Cefoxitin—Local reaction—Mitoxantrone—lymphatic system cancer	0.0131	0.0131	CcSEcCtD
Cefoxitin—Nephropathy toxic—Mitoxantrone—lymphatic system cancer	0.0126	0.0126	CcSEcCtD
Cefoxitin—Phlebitis—Teniposide—lymphatic system cancer	0.0117	0.0117	CcSEcCtD
Cefoxitin—Hepatic function abnormal—Teniposide—lymphatic system cancer	0.0115	0.0115	CcSEcCtD
Cefoxitin—Pancytopenia—Mechlorethamine—lymphatic system cancer	0.0112	0.0112	CcSEcCtD
Cefoxitin—Haemolytic anaemia—Teniposide—lymphatic system cancer	0.0111	0.0111	CcSEcCtD
Cefoxitin—Bone marrow depression—Vincristine—lymphatic system cancer	0.011	0.011	CcSEcCtD
Cefoxitin—Bone marrow depression—Mitoxantrone—lymphatic system cancer	0.0107	0.0107	CcSEcCtD
Cefoxitin—Phlebitis—Fludarabine—lymphatic system cancer	0.0103	0.0103	CcSEcCtD
Cefoxitin—Jaundice—Mechlorethamine—lymphatic system cancer	0.0103	0.0103	CcSEcCtD
Cefoxitin—Tenderness—Bleomycin—lymphatic system cancer	0.0102	0.0102	CcSEcCtD
Cefoxitin—Agranulocytosis—Mechlorethamine—lymphatic system cancer	0.00982	0.00982	CcSEcCtD
Cefoxitin—Haemoglobin—Mechlorethamine—lymphatic system cancer	0.00949	0.00949	CcSEcCtD
Cefoxitin—Haemorrhage—Mechlorethamine—lymphatic system cancer	0.00945	0.00945	CcSEcCtD
Cefoxitin—Erythema multiforme—Mechlorethamine—lymphatic system cancer	0.00893	0.00893	CcSEcCtD
Cefoxitin—Pancytopenia—Teniposide—lymphatic system cancer	0.00826	0.00826	CcSEcCtD
Cefoxitin—Neutropenia—Teniposide—lymphatic system cancer	0.00813	0.00813	CcSEcCtD
Cefoxitin—Toxic epidermal necrolysis—Fludarabine—lymphatic system cancer	0.00797	0.00797	CcSEcCtD
Cefoxitin—Blood bilirubin increased—Mitoxantrone—lymphatic system cancer	0.00767	0.00767	CcSEcCtD
Cefoxitin—Phlebitis—Bleomycin—lymphatic system cancer	0.00753	0.00753	CcSEcCtD
Cefoxitin—Candida infection—Carmustine—lymphatic system cancer	0.00745	0.00745	CcSEcCtD
Cefoxitin—Leukopenia—Mechlorethamine—lymphatic system cancer	0.00736	0.00736	CcSEcCtD
Cefoxitin—Pancytopenia—Fludarabine—lymphatic system cancer	0.00726	0.00726	CcSEcCtD
Cefoxitin—Neutropenia—Fludarabine—lymphatic system cancer	0.00715	0.00715	CcSEcCtD
Cefoxitin—Haemoglobin—Teniposide—lymphatic system cancer	0.007	0.007	CcSEcCtD
Cefoxitin—Haemorrhage—Teniposide—lymphatic system cancer	0.00696	0.00696	CcSEcCtD
Cefoxitin—Azotaemia—Methotrexate—lymphatic system cancer	0.00678	0.00678	CcSEcCtD
Cefoxitin—Stevens-Johnson syndrome—Fludarabine—lymphatic system cancer	0.00676	0.00676	CcSEcCtD
Cefoxitin—Anaphylactic shock—Mechlorethamine—lymphatic system cancer	0.00671	0.00671	CcSEcCtD
Cefoxitin—Phlebitis—Carmustine—lymphatic system cancer	0.00657	0.00657	CcSEcCtD
Cefoxitin—Thrombocytopenia—Mechlorethamine—lymphatic system cancer	0.00657	0.00657	CcSEcCtD
Cefoxitin—Thrombophlebitis—Carmustine—lymphatic system cancer	0.00654	0.00654	CcSEcCtD
Cefoxitin—Flushing—Teniposide—lymphatic system cancer	0.00646	0.00646	CcSEcCtD
Cefoxitin—Haemoglobin—Fludarabine—lymphatic system cancer	0.00615	0.00615	CcSEcCtD
Cefoxitin—Haemorrhage—Fludarabine—lymphatic system cancer	0.00612	0.00612	CcSEcCtD
Cefoxitin—Phlebitis—Mitoxantrone—lymphatic system cancer	0.00611	0.00611	CcSEcCtD
Cefoxitin—Erythema multiforme—Fludarabine—lymphatic system cancer	0.00579	0.00579	CcSEcCtD
Cefoxitin—Renal failure acute—Mitoxantrone—lymphatic system cancer	0.0057	0.0057	CcSEcCtD
Cefoxitin—Anaemia—Teniposide—lymphatic system cancer	0.0056	0.0056	CcSEcCtD
Cefoxitin—Leukopenia—Teniposide—lymphatic system cancer	0.00543	0.00543	CcSEcCtD
Cefoxitin—Bone marrow depression—Methotrexate—lymphatic system cancer	0.00535	0.00535	CcSEcCtD
Cefoxitin—Pancytopenia—Bleomycin—lymphatic system cancer	0.00532	0.00532	CcSEcCtD
Cefoxitin—Hypersensitivity—Mechlorethamine—lymphatic system cancer	0.00494	0.00494	CcSEcCtD
Cefoxitin—Anaemia—Fludarabine—lymphatic system cancer	0.00492	0.00492	CcSEcCtD
Cefoxitin—Thrombocytopenia—Teniposide—lymphatic system cancer	0.00484	0.00484	CcSEcCtD
Cefoxitin—Leukopenia—Fludarabine—lymphatic system cancer	0.00477	0.00477	CcSEcCtD
Cefoxitin—Pruritus—Mechlorethamine—lymphatic system cancer	0.00475	0.00475	CcSEcCtD
Cefoxitin—Pancytopenia—Carmustine—lymphatic system cancer	0.00465	0.00465	CcSEcCtD
Cefoxitin—Hypotension—Teniposide—lymphatic system cancer	0.00462	0.00462	CcSEcCtD
Cefoxitin—Convulsion—Fludarabine—lymphatic system cancer	0.00462	0.00462	CcSEcCtD
Cefoxitin—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.00459	0.00459	CcSEcCtD
Cefoxitin—Neutropenia—Carmustine—lymphatic system cancer	0.00458	0.00458	CcSEcCtD
Cefoxitin—Haemoglobin—Bleomycin—lymphatic system cancer	0.00451	0.00451	CcSEcCtD
Cefoxitin—Haemorrhage—Bleomycin—lymphatic system cancer	0.00449	0.00449	CcSEcCtD
Cefoxitin—Pancytopenia—Vincristine—lymphatic system cancer	0.00444	0.00444	CcSEcCtD
Cefoxitin—Dyspnoea—Teniposide—lymphatic system cancer	0.00441	0.00441	CcSEcCtD
Cefoxitin—Neutropenia—Vincristine—lymphatic system cancer	0.00437	0.00437	CcSEcCtD
Cefoxitin—Anaphylactic shock—Fludarabine—lymphatic system cancer	0.00435	0.00435	CcSEcCtD
Cefoxitin—Pancytopenia—Mitoxantrone—lymphatic system cancer	0.00432	0.00432	CcSEcCtD
Cefoxitin—Vomiting—Mechlorethamine—lymphatic system cancer	0.00427	0.00427	CcSEcCtD
Cefoxitin—Thrombocytopenia—Fludarabine—lymphatic system cancer	0.00426	0.00426	CcSEcCtD
Cefoxitin—Neutropenia—Mitoxantrone—lymphatic system cancer	0.00425	0.00425	CcSEcCtD
Cefoxitin—Rash—Mechlorethamine—lymphatic system cancer	0.00423	0.00423	CcSEcCtD
Cefoxitin—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00423	0.00423	CcSEcCtD
Cefoxitin—Flushing—Bleomycin—lymphatic system cancer	0.00416	0.00416	CcSEcCtD
Cefoxitin—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.00405	0.00405	CcSEcCtD
Cefoxitin—Nausea—Mechlorethamine—lymphatic system cancer	0.00399	0.00399	CcSEcCtD
Cefoxitin—Jaundice—Mitoxantrone—lymphatic system cancer	0.00395	0.00395	CcSEcCtD
Cefoxitin—Haemoglobin—Carmustine—lymphatic system cancer	0.00394	0.00394	CcSEcCtD
Cefoxitin—Urticaria—Teniposide—lymphatic system cancer	0.00393	0.00393	CcSEcCtD
Cefoxitin—Haemorrhage—Carmustine—lymphatic system cancer	0.00392	0.00392	CcSEcCtD
Cefoxitin—Abdominal pain—Teniposide—lymphatic system cancer	0.00391	0.00391	CcSEcCtD
Cefoxitin—Body temperature increased—Teniposide—lymphatic system cancer	0.00391	0.00391	CcSEcCtD
Cefoxitin—Erythema—Bleomycin—lymphatic system cancer	0.00391	0.00391	CcSEcCtD
Cefoxitin—Dyspnoea—Fludarabine—lymphatic system cancer	0.00388	0.00388	CcSEcCtD
Cefoxitin—Agranulocytosis—Mitoxantrone—lymphatic system cancer	0.00379	0.00379	CcSEcCtD
Cefoxitin—Pain—Fludarabine—lymphatic system cancer	0.00372	0.00372	CcSEcCtD
Cefoxitin—Urinary tract disorder—Vincristine—lymphatic system cancer	0.00369	0.00369	CcSEcCtD
Cefoxitin—Urethral disorder—Vincristine—lymphatic system cancer	0.00367	0.00367	CcSEcCtD
Cefoxitin—Haemoglobin—Mitoxantrone—lymphatic system cancer	0.00366	0.00366	CcSEcCtD
Cefoxitin—Hypersensitivity—Teniposide—lymphatic system cancer	0.00364	0.00364	CcSEcCtD
Cefoxitin—Haemorrhage—Mitoxantrone—lymphatic system cancer	0.00364	0.00364	CcSEcCtD
Cefoxitin—Flushing—Carmustine—lymphatic system cancer	0.00364	0.00364	CcSEcCtD
Cefoxitin—Vaginal inflammation—Methotrexate—lymphatic system cancer	0.00361	0.00361	CcSEcCtD
Cefoxitin—Anaemia—Bleomycin—lymphatic system cancer	0.00361	0.00361	CcSEcCtD
Cefoxitin—Pruritus—Teniposide—lymphatic system cancer	0.0035	0.0035	CcSEcCtD
Cefoxitin—Leukopenia—Bleomycin—lymphatic system cancer	0.0035	0.0035	CcSEcCtD
Cefoxitin—Body temperature increased—Fludarabine—lymphatic system cancer	0.00344	0.00344	CcSEcCtD
Cefoxitin—Vaginal infection—Methotrexate—lymphatic system cancer	0.00341	0.00341	CcSEcCtD
Cefoxitin—Erythema—Carmustine—lymphatic system cancer	0.00341	0.00341	CcSEcCtD
Cefoxitin—Aplastic anaemia—Methotrexate—lymphatic system cancer	0.00339	0.00339	CcSEcCtD
Cefoxitin—Diarrhoea—Teniposide—lymphatic system cancer	0.00338	0.00338	CcSEcCtD
Cefoxitin—Hypersensitivity—Fludarabine—lymphatic system cancer	0.0032	0.0032	CcSEcCtD
Cefoxitin—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.00319	0.00319	CcSEcCtD
Cefoxitin—Erythema—Mitoxantrone—lymphatic system cancer	0.00317	0.00317	CcSEcCtD
Cefoxitin—Anaemia—Carmustine—lymphatic system cancer	0.00315	0.00315	CcSEcCtD
Cefoxitin—Vomiting—Teniposide—lymphatic system cancer	0.00315	0.00315	CcSEcCtD
Cefoxitin—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.00312	0.00312	CcSEcCtD
Cefoxitin—Rash—Teniposide—lymphatic system cancer	0.00312	0.00312	CcSEcCtD
Cefoxitin—Dermatitis—Teniposide—lymphatic system cancer	0.00312	0.00312	CcSEcCtD
Cefoxitin—Pruritus—Fludarabine—lymphatic system cancer	0.00308	0.00308	CcSEcCtD
Cefoxitin—Leukopenia—Carmustine—lymphatic system cancer	0.00305	0.00305	CcSEcCtD
Cefoxitin—Thrombophlebitis—Methotrexate—lymphatic system cancer	0.00303	0.00303	CcSEcCtD
Cefoxitin—Anaemia—Vincristine—lymphatic system cancer	0.00301	0.00301	CcSEcCtD
Cefoxitin—Hypotension—Bleomycin—lymphatic system cancer	0.00298	0.00298	CcSEcCtD
Cefoxitin—Diarrhoea—Fludarabine—lymphatic system cancer	0.00297	0.00297	CcSEcCtD
Cefoxitin—Convulsion—Carmustine—lymphatic system cancer	0.00295	0.00295	CcSEcCtD
Cefoxitin—Nausea—Teniposide—lymphatic system cancer	0.00294	0.00294	CcSEcCtD
Cefoxitin—Anaemia—Mitoxantrone—lymphatic system cancer	0.00293	0.00293	CcSEcCtD
Cefoxitin—Leukopenia—Vincristine—lymphatic system cancer	0.00291	0.00291	CcSEcCtD
Cefoxitin—Dyspnoea—Bleomycin—lymphatic system cancer	0.00284	0.00284	CcSEcCtD
Cefoxitin—Renal failure acute—Methotrexate—lymphatic system cancer	0.00284	0.00284	CcSEcCtD
Cefoxitin—Leukopenia—Mitoxantrone—lymphatic system cancer	0.00284	0.00284	CcSEcCtD
Cefoxitin—Convulsion—Vincristine—lymphatic system cancer	0.00282	0.00282	CcSEcCtD
Cefoxitin—Dermatitis exfoliative—Methotrexate—lymphatic system cancer	0.00278	0.00278	CcSEcCtD
Cefoxitin—Vomiting—Fludarabine—lymphatic system cancer	0.00276	0.00276	CcSEcCtD
Cefoxitin—Convulsion—Mitoxantrone—lymphatic system cancer	0.00275	0.00275	CcSEcCtD
Cefoxitin—Rash—Fludarabine—lymphatic system cancer	0.00274	0.00274	CcSEcCtD
Cefoxitin—Dermatitis—Fludarabine—lymphatic system cancer	0.00274	0.00274	CcSEcCtD
Cefoxitin—Pain—Bleomycin—lymphatic system cancer	0.00273	0.00273	CcSEcCtD
Cefoxitin—Thrombocytopenia—Carmustine—lymphatic system cancer	0.00272	0.00272	CcSEcCtD
Cefoxitin—Anaphylactic shock—Vincristine—lymphatic system cancer	0.00266	0.00266	CcSEcCtD
Cefoxitin—Thrombocytopenia—Vincristine—lymphatic system cancer	0.0026	0.0026	CcSEcCtD
Cefoxitin—Hypotension—Carmustine—lymphatic system cancer	0.0026	0.0026	CcSEcCtD
Cefoxitin—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.00259	0.00259	CcSEcCtD
Cefoxitin—Nausea—Fludarabine—lymphatic system cancer	0.00258	0.00258	CcSEcCtD
Cefoxitin—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.00253	0.00253	CcSEcCtD
Cefoxitin—Urticaria—Bleomycin—lymphatic system cancer	0.00253	0.00253	CcSEcCtD
Cefoxitin—Body temperature increased—Bleomycin—lymphatic system cancer	0.00252	0.00252	CcSEcCtD
Cefoxitin—Hypotension—Vincristine—lymphatic system cancer	0.00248	0.00248	CcSEcCtD
Cefoxitin—Dyspnoea—Carmustine—lymphatic system cancer	0.00248	0.00248	CcSEcCtD
Cefoxitin—Hypotension—Mitoxantrone—lymphatic system cancer	0.00242	0.00242	CcSEcCtD
Cefoxitin—Pain—Carmustine—lymphatic system cancer	0.00238	0.00238	CcSEcCtD
Cefoxitin—Toxic epidermal necrolysis—Methotrexate—lymphatic system cancer	0.00236	0.00236	CcSEcCtD
Cefoxitin—Hypersensitivity—Bleomycin—lymphatic system cancer	0.00235	0.00235	CcSEcCtD
Cefoxitin—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.00231	0.00231	CcSEcCtD
Cefoxitin—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.00228	0.00228	CcSEcCtD
Cefoxitin—Pain—Vincristine—lymphatic system cancer	0.00227	0.00227	CcSEcCtD
Cefoxitin—Pruritus—Bleomycin—lymphatic system cancer	0.00226	0.00226	CcSEcCtD
Cefoxitin—Eosinophilia—Methotrexate—lymphatic system cancer	0.00224	0.00224	CcSEcCtD
Cefoxitin—Pain—Mitoxantrone—lymphatic system cancer	0.00221	0.00221	CcSEcCtD
Cefoxitin—Body temperature increased—Carmustine—lymphatic system cancer	0.0022	0.0022	CcSEcCtD
Cefoxitin—Abdominal pain—Carmustine—lymphatic system cancer	0.0022	0.0022	CcSEcCtD
Cefoxitin—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.00217	0.00217	CcSEcCtD
Cefoxitin—Pancytopenia—Methotrexate—lymphatic system cancer	0.00215	0.00215	CcSEcCtD
Cefoxitin—Neutropenia—Methotrexate—lymphatic system cancer	0.00212	0.00212	CcSEcCtD
Cefoxitin—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.00212	0.00212	CcSEcCtD
Cefoxitin—Body temperature increased—Vincristine—lymphatic system cancer	0.0021	0.0021	CcSEcCtD
Cefoxitin—Abdominal pain—Vincristine—lymphatic system cancer	0.0021	0.0021	CcSEcCtD
Cefoxitin—Urticaria—Mitoxantrone—lymphatic system cancer	0.00206	0.00206	CcSEcCtD
Cefoxitin—Hypersensitivity—Carmustine—lymphatic system cancer	0.00205	0.00205	CcSEcCtD
Cefoxitin—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.00205	0.00205	CcSEcCtD
Cefoxitin—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.00205	0.00205	CcSEcCtD
Cefoxitin—Vomiting—Bleomycin—lymphatic system cancer	0.00203	0.00203	CcSEcCtD
Cefoxitin—Rash—Bleomycin—lymphatic system cancer	0.00201	0.00201	CcSEcCtD
Cefoxitin—Dermatitis—Bleomycin—lymphatic system cancer	0.00201	0.00201	CcSEcCtD
Cefoxitin—Stevens-Johnson syndrome—Methotrexate—lymphatic system cancer	0.002	0.002	CcSEcCtD
Cefoxitin—Hypersensitivity—Vincristine—lymphatic system cancer	0.00196	0.00196	CcSEcCtD
Cefoxitin—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.00191	0.00191	CcSEcCtD
Cefoxitin—Diarrhoea—Carmustine—lymphatic system cancer	0.0019	0.0019	CcSEcCtD
Cefoxitin—Nausea—Bleomycin—lymphatic system cancer	0.00189	0.00189	CcSEcCtD
Cefoxitin—Agranulocytosis—Methotrexate—lymphatic system cancer	0.00189	0.00189	CcSEcCtD
Cefoxitin—Haemoglobin—Methotrexate—lymphatic system cancer	0.00182	0.00182	CcSEcCtD
Cefoxitin—Diarrhoea—Vincristine—lymphatic system cancer	0.00182	0.00182	CcSEcCtD
Cefoxitin—Haemorrhage—Methotrexate—lymphatic system cancer	0.00181	0.00181	CcSEcCtD
Cefoxitin—Urinary tract disorder—Methotrexate—lymphatic system cancer	0.00179	0.00179	CcSEcCtD
Cefoxitin—Urethral disorder—Methotrexate—lymphatic system cancer	0.00178	0.00178	CcSEcCtD
Cefoxitin—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.00177	0.00177	CcSEcCtD
Cefoxitin—Vomiting—Carmustine—lymphatic system cancer	0.00177	0.00177	CcSEcCtD
Cefoxitin—Rash—Carmustine—lymphatic system cancer	0.00175	0.00175	CcSEcCtD
Cefoxitin—Dermatitis—Carmustine—lymphatic system cancer	0.00175	0.00175	CcSEcCtD
Cefoxitin—Erythema multiforme—Methotrexate—lymphatic system cancer	0.00172	0.00172	CcSEcCtD
Cefoxitin—Vomiting—Vincristine—lymphatic system cancer	0.00169	0.00169	CcSEcCtD
Cefoxitin—Rash—Vincristine—lymphatic system cancer	0.00167	0.00167	CcSEcCtD
Cefoxitin—Dermatitis—Vincristine—lymphatic system cancer	0.00167	0.00167	CcSEcCtD
Cefoxitin—Nausea—Carmustine—lymphatic system cancer	0.00165	0.00165	CcSEcCtD
Cefoxitin—Vomiting—Mitoxantrone—lymphatic system cancer	0.00164	0.00164	CcSEcCtD
Cefoxitin—Rash—Mitoxantrone—lymphatic system cancer	0.00163	0.00163	CcSEcCtD
Cefoxitin—Dermatitis—Mitoxantrone—lymphatic system cancer	0.00163	0.00163	CcSEcCtD
Cefoxitin—Erythema—Methotrexate—lymphatic system cancer	0.00158	0.00158	CcSEcCtD
Cefoxitin—Nausea—Vincristine—lymphatic system cancer	0.00158	0.00158	CcSEcCtD
Cefoxitin—Nausea—Mitoxantrone—lymphatic system cancer	0.00154	0.00154	CcSEcCtD
Cefoxitin—Anaemia—Methotrexate—lymphatic system cancer	0.00146	0.00146	CcSEcCtD
Cefoxitin—Leukopenia—Methotrexate—lymphatic system cancer	0.00141	0.00141	CcSEcCtD
Cefoxitin—Convulsion—Methotrexate—lymphatic system cancer	0.00137	0.00137	CcSEcCtD
Cefoxitin—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.00129	0.00129	CcSEcCtD
Cefoxitin—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.00126	0.00126	CcSEcCtD
Cefoxitin—Hypotension—Methotrexate—lymphatic system cancer	0.0012	0.0012	CcSEcCtD
Cefoxitin—Dyspnoea—Methotrexate—lymphatic system cancer	0.00115	0.00115	CcSEcCtD
Cefoxitin—Pain—Methotrexate—lymphatic system cancer	0.0011	0.0011	CcSEcCtD
Cefoxitin—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.00105	0.00105	CcSEcCtD
Cefoxitin—Urticaria—Methotrexate—lymphatic system cancer	0.00102	0.00102	CcSEcCtD
Cefoxitin—Abdominal pain—Methotrexate—lymphatic system cancer	0.00102	0.00102	CcSEcCtD
Cefoxitin—Body temperature increased—Methotrexate—lymphatic system cancer	0.00102	0.00102	CcSEcCtD
Cefoxitin—Hypersensitivity—Methotrexate—lymphatic system cancer	0.00095	0.00095	CcSEcCtD
Cefoxitin—Pruritus—Methotrexate—lymphatic system cancer	0.000912	0.000912	CcSEcCtD
Cefoxitin—Diarrhoea—Methotrexate—lymphatic system cancer	0.000882	0.000882	CcSEcCtD
Cefoxitin—Vomiting—Methotrexate—lymphatic system cancer	0.00082	0.00082	CcSEcCtD
Cefoxitin—Rash—Methotrexate—lymphatic system cancer	0.000813	0.000813	CcSEcCtD
Cefoxitin—Dermatitis—Methotrexate—lymphatic system cancer	0.000812	0.000812	CcSEcCtD
Cefoxitin—Nausea—Methotrexate—lymphatic system cancer	0.000766	0.000766	CcSEcCtD
